Avrobio Inc reported $226.44M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Akebia Therapeutics AKBA:US $ 246.99M 5.77M
Alnylam Pharmaceuticals ALNY:US $ 745.77M 366.22M
Applied Genetic Technologies AGTC:US $ 105.05M 15.52M
Bluebird Bio BLUE:US $ 353.47M 86.25M
Epizyme EPZM:US $ 80.16M 6.45M
Gilead Sciences GILD:US $ 7361M 3296M
Intercept Pharmaceuticals ICPT:US $ 145.62M 52.67M
Karyopharm Therapeutics KPTI:US $ 141.31M 52.84M
Macrogenics MGNX:US $ 188.97M 29.53M
Sangamo Biosciences SGMO:US $ 169.88M 46.9M
Sarepta Therapeutics SRPT:US $ 1697.28M 215.44M
Takeda 4502:JP Y 654920M 311302M